← All trials
NCT03807102
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 16, 2019
- Primary completion
- Jan 31, 2020
- Completion date
- Jan 31, 2023
- First posted
- —
- Last posted
- —
- Enrollment
- 30
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Hunan Provincal Tumor HospitalLead sponsor
- Central South UniversitySponsor investigator
- Shanghai Houchao Biotechnology Co., LtdCollaborator
- Hunan Provincal Tumor HospitalOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.